|
|
|
Volume 6, Issue 6, June 1999, in PDF
|
   |
Article 125: Medical Device Grants Market Soars
- Spending on clinical trials for medical devices is increasing, not only for devices that require testing for the FDA, but also for devices that are substantially equivalent to devices already on the market. This data is used for the company's safety and efficacy assurance.
- Unlike four years ago, medical device companies are not flocking to Europe to conduct clinical trials. Rather, more and more companies are choosing to test their devices in the United States first.
Article 126: A Word From Clinical Trial Volunteers
- Results of a CenterWatch survey of 210 patients indicate that the vast majority of patients have had positive experiences participating in clinical trials. These results are in sharp contrast with recent reports in the media.
- A high percentage of patients find that investigative site staff are professional, knowledgeable and provide a high level of care.
Article 127: CentreStage Europe: An SMO's Growth Challenges
- This is a new section debuting this month. CentreStage Europe will focus on trends, company practices and issues specific to the clinical trials industry in Europe.
- This month, CenterWatch focuses on ProTest, an SMO based in Paris, and its plans for expansion.
Article 128: Eye On Ovarian Cancer
- The lack of ovarian cancer diagnostics requires new, more effective therapies. CenterWatch editorial estimates the ovarian cancer grant market as about $150 million.
Price: $59.00
|
|
|